Boston Scientific (BSX) Director David C. Habiger Buys Shares

What Happened
David C. Habiger, a director of Boston Scientific (BSX), made open-market purchases of company stock. On 2026-08-03 he acquired 1,042 shares at an average price of $48.07 for a reported total of $50,084, and on 2026-08-04 he acquired 140 shares at an average price of $48.59 for a reported total of $6,802. Combined, the purchases total 1,182 shares for approximately $56,886. These were outright purchases (transaction code P).

Key Details

• Transaction dates and prices:
  • 2026-08-03: 1,042 shares @ $48.07 (total $50,084). Footnote F1: weighted average price covering multiple trades priced $48.055–$48.070.
  • 2026-08-04: 140 shares @ $48.59 (total $6,802). Footnote F2: weighted average price covering multiple trades priced $48.54–$48.60.
• Shares owned after transaction: Not specified in this Form 4 filing.
• Filing timeliness: Form 4 filed 2026-08-05 for transactions on 2026-08-03 and 2026-08-04 (filed within the typical 2‑business‑day window).
• Nature of transaction: Open-market purchases (P). No option exercise, award, gift, or tax-withholding noted.

Context
These are direct purchases by a company director, not option exercises or awards. Purchases by insiders are often watched by investors as a sign of confidence, but they do not guarantee future performance. The total reported purchase amount is modest (~$56.9K) relative to large institutional moves; retail investors should consider this as one data point among many when assessing the stock.